{
  "docId": "019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "docSlug": "e0f48061a961c5e04d59dc15b9a47e3c",
  "documentTitle": "MindMed | Investor Presentation Deck | 36 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 36,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart shows a comparison between Placebo and MDMA at 1 month and 6 months, indicating sustained improvement.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2dc4-7413-a6ea-ecd3ab0cc295/22",
  "deckHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "deckJsonHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295.json",
  "deckAnchorHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.53,
        "y": 0.26
      },
      "kind": "chart",
      "text": "MDMA Reduces Social Anxiety in ASD",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "873cd850-438a-4e41-9b2f-a37a2870932b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "list",
      "text": "Potential first-in-class therapy for core symptoms of ASD; Pilot clinical data suggest racemic MDMA could enhance social functioning; Pharmacological profile aligns with patient-desired treatment benefits",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67b12b02-dc17-4779-97d3-4cec314cd981",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "1. Danforth 2018; Psychopharmacology; 235. MDMA: 3,4-methylenedioxymethamphetamine; ASD: Autism Spectrum Disorder",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cc0ee79-dd76-45f7-bacc-bfd0165b2073",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "subtitle",
      "text": "Pilot clinical trial results of MDMA demonstrate acute and durable positive effects on social functioning in ASD population",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d6d2baf2-7874-405c-ad1e-da9e1a2bfcff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Clinical Data Support Opportunity for MDMA in ASD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78bd269a-c8a4-4c30-bff7-fecdb2bf659c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}